Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-12-06

Clinical Trial Update: Using Soy Estrogens to Prevent Bone Loss and Other Menopausal Symptoms [Phase 3]

View source ↗

Summary

Phase 3 trial assessing soy isoflavones to prevent bone loss and alleviate menopausal symptoms has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Soy Isoflavones (isoflavones from soy)

Snippet

Sponsor: University of Miami | Conditions: Menopause, Osteoporosis | Phase 3 | Status: COMPLETED | Results posted: 2016-12-06